Differences in Clinical Profile and Relapse Rate of Type 1 Versus Type 2 Autoimmune Pancreatitis

Gastroenterology

Volumn 139, Issue 1, 2010, Pages 140-148

  Sah, Raghuwansh P ^a   Chari, Suresh T ^a   Pannala, Rahul ^a   Sugumar, Aravind ^a   Clain, Jonathan E ^a   Levy, Michael J ^a   Pearson, Randall K ^a   Smyrk, Thomas C ^a   Petersen, Bret T ^a   Topazian, Mark D ^a   Takahashi, Naoki ^a   Farnell, Michael B ^a   Vege, Santhi S ^a  

^a MAYO CLINIC   (United States)

Author keywords

Autoimmunity; Chronic Pancreatitis; Corticosteroid Therapy; IgG4 Related Systemic Disease

Indexed keywords

PREDNISONE;

ADULT; AGED; ARTICLE; AUTOIMMUNE PANCREATITIS; BILIARY TRACT DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PANCREATICODUODENECTOMY; PREVALENCE; PRIORITY JOURNAL; RELAPSE; RETROPERITONEAL DISEASE; SALIVARY GLAND DISEASE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 77953890776     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.03.054     Document Type: Article

References (45)

1. Gardner T.B., and Chari S.T. Autoimmune pancreatitis. Gastroenterol Clin North Am 37 (2008) 439-460 vii
2. Pannala R., and Chari S.T. Autoimmune pancreatitis. Curr Opin Gastroenterol 24 (2008) 591-596
3. Chari S.T., and Murray J.A. Autoimmune pancreatitis. Part II: the relapse. Gastroenterology 134 (2008) 625-628
4. Chari S.T., Smyrk T.C., Levy M.J., et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 4 (2006) 1010-1016
5. Notohara K., Burgart L.J., Yadav D., et al. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol 27 (2003) 1119-1127
6. Zamboni G., Luttges J., Capelli P., et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 445 (2004) 552-563
7. Park D.H., Kim M.H., and Chari S.T. Recent advances in autoimmune pancreatitis. Gut 58 (2009) 1680-1689
8. Zhang L., Notohara K., Levy M.J., et al. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol 20 (2007) 23-28
9. Kamisawa T., Funata N., and Hayashi Y. Lymphoplasmacytic sclerosing pancreatitis is a pancreatic lesion of igG4-related systemic disease. Am J Surg Pathol 28 (2004) 1114
10. Kamisawa T., Nakajima H., Egawa N., et al. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy. Pancreatology 6 (2006) 132-137
11. Deshpande V., Chicano S., Finkelberg D., et al. Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol 30 (2006) 1537-1545
12. Ghazale A., Chari S.T., Zhang L., et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to steroids. Gastroenterology 134 (2008) 760-765
13. Yamamoto N., Fletcher J.G., Fidler J.L., et al. Mikulicz's disease and systemic IgG4-related plasmacytic syndrome (SIPS). Nihon Rinsho Meneki Gakkai Kaishi 31 (2008) 1-8
14. Takahashi N., Kawashima A., Fletcher J.G., et al. Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiology 242 (2007) 791-801
15. Cornell L.D., Chicano S.L., Deshpande V., et al. Pseudotumors due to IgG4 immune complex tubulointerstitial nephritis associated with autoimmune pancreatitocentric disease. Am J Surg Pathol 31 (2007) 1586-1597
16. Okazaki K., and Chiba T. Autoimmune related pancreatitis. Gut 51 (2002) 1-4
17. Otsuki M., Chung J.B., Okazaki K., et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol 43 (2008) 403-408
18. Chari S.T., Takahashi N., Levy M.J., et al. A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol 7 (2009) 1097
19. Kamisawa T., Yoshiike M., Egawa N., et al. Treating patients with autoimmune pancreatitis: results from a long-term follow-up study. Pancreatology 5 (2005) 234-238
20. Hirano K., Tada M., Isayama H., et al. Long term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut 56 (2007) 1719-1724
21. Ito T., Nishimori I., Inoue N., et al. Treatment of autoimmune pancreatitis: consensus on the treatment for patients with autoimmune pancreatitis in Japan. J Gastroenterol 42 Suppl XVIII (2007) 50-58
22. Ghazale A., and Chari S. Optimising corticosteroid treatment for autoimmune pancreatitis. Gut 56 (2007) 1650-1652
23. Kamisawa T., Shimosegawa T., Okazaki K., et al. Standard steroid therapy for autoimmune pancreatitis. Gut 58 (2009) 1504-1507
24. Kamisawa T., Okamoto A., Wakabayashi T., et al. Appropriate steroid therapy for autoimmune pancreatitis based on long term outcome. Scand J Gastroenterol 43 (2008) 609-613
25. Nishino T., Toki F., Oyama H., et al. Long term outcome of autoimmune pancreatitis after oral prednisolone therapy. Intern Med 45 (2006) 497-501
26. Wakabayashi T., Kawaura Y., Satomura Y., et al. Long term prognosis of duct narrowing chronic pancreatitis. Strategy for steroid treatment. Pancreas 30 (2005) 31-39
27. Church N.I., Pereira S.P., Deheragoda M.G., et al. Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series. Am J Gastroenterol 102 (2007) 2417-2425
28. Kubota K., Iida H., Fujisawa T., et al. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis. Gastroenterol Endosc 66 (2007) 1142-1151
29. Ryu K.J., Chung J.B., Park S.W., et al. Review of 67 patients with autoimmune pancreatitis in Korea-a multicenter nationwide study. Pancreas 37 (2008) 377-385
30. Frulloni L., Scattolini C., Falconi M., et al. Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am J Gastroenterol 104 (2009) 2288-2294
31. Kamisawa T., and Atsutake O. Prognosis of autoimmune pancreatitis. J Gastroenterol 42 Suppl XVIII (2007) 59-62
32. Takayama M., Hamano H., Ochi Y., et al. Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation. Am J Gastroenterol 99 (2004) 932-937
33. Kim K.P., Kim M.H., Dong M.H., et al. Autoimmune chronic pancreatitis. Am J Gastroenterol 99 (2004) 1605-1616
34. Raina A., Yadav D., Krasinskas A.M., et al. Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol 104 (2009) 2295-2306
35. Sandanayake N.S., Church N.I., Chapman M.H., et al. Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol 7 (2009) 1089
36. Ghazale A., and Chari S.T. Is autoimmune pancreatitis a risk factor for pancreatic cancer?. Pancreas 35 4 (2007) 376
37. Uchida K., Yazumi S., Nishio A., et al. Long term outcome of autoimmune pancreatitis. J Gastroenterol 44 (2009) 726-732
38. Inoue H., Miyatani H., Sawada Y., et al. A case of pancreas cancer with autoimmune pancreatitis. Pancreas 33 (2006) 208-209
39. Sugumar A., Kloppel G., and Chari S.T. Autoimmune pancreatitis: pathologic subtypes and their implications for its diagnosis. Am J Gastroenterol 104 (2009) 2308-2310
40. Frulloni L., Lunardi C., Simone R., et al. Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med 361 (2009) 2135-2142
41. Ravi K., Chari S.T., Vege S.S., et al. Inflammatory bowel disease in the setting of autoimmune pancreatitis. Inflamm Bowel Dis 15 (2009) 1326-1330
42. Ozden I., Dizdarogly F., Poyanli A., et al. Spontaneous regression of a pancreatic head mass and biliary obstruction due to autoimmune pancreatitis. Pancreatology 5 (2005) 300-303
43. Wakabayashi T., Motoo Y., Kojima Y., et al. Chronic pancreatitis with diffuse irregular narrowing of the main pancreatic duct. Dig Dis Sci 43 (1998) 2415-2425
44. Sahani D.V., Sainani N.I., Deshpande V., et al. Autoimmune pancreatitis: disease evolution, staging, response assessment and CT features that predict response to corticosteroid therapy. Radiology 250 (2009) 118-129
45. Takahashi N., Ghazale A.H., Smyrk T.C., et al. Possible association between IgG4-associated systemic disease with or without autoimmune pancreatitis and non-Hodgkin lymphoma. Pancreas 38 (2009) 523-526